Description
| Strength | 40 mg |
| Brand Name | Roxopar 40 |
| Manufacturer | Intelico Pharmaceuticals Private Limited |
| Packaging Type | Box |
| Usage/Application | To Prevent Deep Venous Thrombosis |
| Shelf Life | 24 Months |
| Composition | Enoxaparin Sodium |
| Form | Injection |
Product’s Details:
- Roxopar 40 mg Enoxaparin Sodium Injection is a trusted anticoagulant belonging to the low molecular weight heparin (LMWH) class. It is widely prescribed to prevent and treat blood clots, including DVT and PE, particularly in post-surgical, immobilized, or critically ill patients. Compared to unfractionated heparin, it offers greater safety and predictable efficacy.
- Composition:Each prefilled syringe contains 40 mg (0.4 ml) of Enoxaparin Sodium in sterile solution for subcutaneous injection.
- Features & Benefits:
- Effectively prevents deep vein thrombosis and pulmonary embolism
- Safer and more predictable than unfractionated heparin
- Suitable for post-surgical and immobilized patients
- Convenient prefilled syringe for ease of administration
- Backed by proven clinical efficacy and safety
- Side Effects: Common side effects may include:
- Mild bleeding or bruising at the injection site
- Headache or dizziness
- Rash or irritation
- Mild fever
Severe (rare) side effects:
- Severe bleeding
- Allergic or hypersensitivity reactions
- Low platelet count (thrombocytopenia)
- Spinal/epidural hematoma (in high-risk patients)
- Storage:
- Store at room temperature (up to 25°C)
- Do not freeze
- Protect from light and excessive heat
- Keep in original packaging until use
Reviews
There are no reviews yet.